DoDI 1010.01 军人药物滥用检测计划(MPDATP).pdf
Department of Defense INSTRUCTION NUMBER 1010.01 September 13,2012 Incorporating Change 1,Effective February 14,2018 USD(P&R)SUBJECT:Military Personnel Drug Abuse Testing Program(MPDATP)References:See Enclosure 1 1.PURPOSE.This Instruction:a.Reissues DoD Directive(DoDD)1010.1(Reference(a)as a DoD Instruction(DoDI)in accordance with the authority in DoDD 5124.02(Reference(b).b.Updates established policy and assigned responsibilities of the MPDATP.MPDATP guidance is provided in Enclosure 2.c.Realigns responsibilities for drug detection and deterrence policy,education,and oversight in accordance with the policy in DoDD 1010.4(Reference(c).Technical guidance for the Forensic Drug Testing Laboratories is provided in DoDI 1010.16(Reference(d).d.Incorporates and cancels the Assistant Secretary of Defense for Special Operations and Low Intensity Conflict memorandum(Reference(e).e.Issues guidance on the conduct of prevalence testing and the use of data from urinalysis testing to conduct demographic longitudinal,statistical,and analytical studies assessing the extent of drug abuse among military personnel within DoD.2.APPLICABILITY.This Instruction:a.Applies to OSD,the Military Departments,
展开阅读全文
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- DoDI 1010.01 军人药物滥用检测计划MPDATP 军人 药物 滥用 检测 计划 MPDATP

关于本文